Patents
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
09/2001
09/11/2001US6288246 Reaction of hydroxylamine with alkylsilyl halide, hydrolysis with acid
09/11/2001US6288231 Peptide-containing α-ketoamide cysteine and serine protease inhibitors
09/11/2001US6288187 Perfluorovinyl ionic compounds and their use in conductive materials
09/11/2001US6288157 Alkylated fluorochemical oligomers and use thereof
09/11/2001US6288120 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
09/11/2001US6288063 Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
09/11/2001US6288055 Analgesic agents
09/07/2001WO2001064643A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
09/07/2001WO2001064642A2 Benzamides and related inhibitors of factor xa
09/07/2001WO2001064619A1 Fluorine compounds and water- and oil-repellant compositions
09/07/2001WO2000075107A3 Bradykinin receptor antagonists
09/06/2001US20010020113 Placing a nucleophile, whose nucleophilic atom is advantageously a nitrogen, in contact with a sulphonyl halide and an organic base
09/06/2001US20010020092 Nitro-sulfobenzamides
09/05/2001CN1311773A Neuropeptide Y5 receptor antagonists
09/05/2001CN1311772A New 3-aryl-2-hydoxy-propionic acid derivative I
09/05/2001CN1311769A New 3-aryl-2-hydroxypropionic acid derivative III
09/04/2001USH1992 Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their pharmaceutical uses
09/04/2001US6284924 Bis/oxynaphthalene derivatives of carboxylic acids
09/04/2001US6284923 Benzenesulfonimides for treatment of cancer and anticholesterol agents
09/04/2001US6284912 Process for synthesizing para-and/or meta-substituted cyanophenyalanine derivatives
09/04/2001US6284796 Naphthamidine compounds
09/04/2001US6284795 Sulfonamide compounds and methods of treating atherosclerosis and restenosis
09/04/2001US6284777 Carbohydrazide protease inhibitors
08/2001
08/30/2001WO2001062718A1 Benzamide derivative and use thereof
08/30/2001WO2001062717A1 Aminosulfonylbiphenyl derivatives
08/30/2001WO2001062705A2 Aminoalcohol derivatives
08/30/2001WO2000071510A3 INHIBITORS OF FACTOR Xa
08/30/2001US20010018523 Sulfonamide compounds and methods of treating atherosclerosis and restenosis
08/30/2001US20010018441 Antiinflammatory agent, immunosuppressant, anticancer agents, antiarthritic agents
08/30/2001US20010018423 Anticoagulant agents
08/30/2001DE10008329A1 New aminosulfonyl-biphenyl derivatives are Factor Xa and Factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, arteriosclerosis, inflammation or angina pectoris
08/30/2001CA2399018A1 Aminosulfonylbiphenyl derivatives
08/29/2001EP1127869A1 Novel compounds and medicinal use thereof
08/29/2001EP1127036A1 Sulphonylation method and reagent useful for perhalogenated sulphanilide synthesis
08/29/2001EP0889877B1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS
08/29/2001CN1310716A Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
08/29/2001CN1310621A Substituted anilide compounds and methods
08/28/2001US6281367 Process for the synthesis of HIV protease inhibitors
08/28/2001US6281357 Headache therapy
08/28/2001US6281246 Pharmaceutical composition with sotalol combination and their use in treatment of cardiac ailments
08/28/2001US6281206 Amidino and benzamidino compounds
08/28/2001US6280883 Electrolytes with conductive salts, cations and anions
08/28/2001CA2017252C Retroviral protease inhibiting compounds
08/23/2001WO2001060803A1 Fused imidazolium derivatives
08/23/2001WO2001060795A1 Processes for preparing optically active amino acid derivatives
08/23/2001WO2001060787A1 Method for the production of nitroethionate
08/23/2001WO2000071508A3 Inhibitors of factor Xa
08/23/2001US20010016659 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
08/23/2001US20010016595 Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases
08/23/2001CA2369678A1 Process for producing optically active amino acid derivatives
08/22/2001EP1124820A1 Lipoic acid derivatives and their use in treatment of disease
08/22/2001EP1124797A1 N-arylsulfonyl amino acid omega amides
08/22/2001EP0696208B1 Oral drug delivery compositions
08/21/2001US6277987 Sulfonylamino acid and sulfonylamino hydroxamic acid derivatives
08/21/2001US6277885 Inhibitors of tumor necrosis factor-alpha converting enzyme
08/21/2001US6277880 Chemical compounds
08/21/2001US6277849 N-sulphonyl and N-sulphinyl amino acid amides as microbiocides
08/16/2001WO2001058853A1 Dehydroamino acids
08/16/2001WO2001058843A1 Process for preparing optically active secondary alcohols having nitrogenous or oxygenic functional groups
08/16/2001WO2000055124A3 Novel compounds and compositions as protease inhibitors
08/16/2001WO2000047551A3 Inhibitors of aspartyl protease
08/16/2001WO2000041531A3 Serine protease inhibitors
08/16/2001EP1144373A3 Serine protease inhibitors
08/16/2001EP1123919A1 Process for producing peptidyl aldehydes
08/16/2001EP1123276A1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
08/16/2001EP1123272A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
08/16/2001DE10006545A1 Verfahren zur Herstellung von Nitroethionat A process for preparing Nitroethionat
08/16/2001CA2397993A1 Dehydroamino acids
08/15/2001CN1308608A Substituted beta-amino acid inhibitors of methionine aminopeptidase-2
08/15/2001CN1308606A Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use pharmaceutical preparations comprising them
08/15/2001CN1308542A Sucoinamide inhibitors of interleukin-1& beta, converting enzyme
08/15/2001CN1308534A Angiogenesis inhibitors
08/15/2001CN1308058A 2-amino-8-naphthol-6-sulfonyl-N-methylaniline and its synthesis
08/15/2001CN1308057A INtermediate for producing 2-trifluoromethoxy benzene sulfonamide
08/15/2001CN1069633C Iodinated X-ray contrast media
08/14/2001US6274584 Peptide derivatives; bioavailability; enzyme resistance; milk and wool production
08/14/2001US6274336 Producing three-dimensional structure of active site using computer program, displaying and superimposing three-dimensional representation of test compound onto active site, preparing test compound, and testing in biological assay
08/09/2001WO2001056962A1 Perfluoroisopropylbenzene derivatives
08/09/2001WO2001056562A1 Stable emulsion compositions
08/09/2001WO2001019788A3 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
08/09/2001WO2000071511A3 INHIBITORS OF FACTOR Xa
08/09/2001WO2000071506A3 Naphthalene ureas as glucose uptake enhancers
08/09/2001WO2000059878A3 INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF
08/09/2001WO2000047554A3 INHIBITORS OF FACTOR Xa
08/09/2001US20010012901 An amidino group linker
08/09/2001US20010012848 An indane-like compounds which can be useful for treating psychosis and other conditions associated with modulation of a muscarinic receptor
08/09/2001US20010012591 Solvents and novel electrolytic compositions having a large range of stability and high conductivity
08/08/2001EP1122240A2 Process for producing sulfonylimide compound
08/08/2001EP1122239A2 Process for producing sulfonylimide compound
08/08/2001EP1121342A1 Diaminopropionic acid derivatives
08/08/2001CN1307599A Aromatic polymers with pendant fluorinated ionic groups
08/08/2001CN1307564A Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them
08/08/2001CN1306959A Prep. of sulfuryl imine compound
08/07/2001US6271419 Process and reagent useful for the synthesis of sulphanilide which is perhalogenated on the carbon borne by the sulphur atom of the sulphanilide function
08/07/2001US6271262 Metalloproteinase inhibitors
08/07/2001US6271261 Chemokine mediated diseases, binding interleukins or beta-receptors and administering to mammals
08/07/2001US6271252 Cyclic amino acid derivatives as cell adhesion inhibitors
08/07/2001US6271247 Binding to neuropeptide receptors
08/02/2001WO2001055146A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF
08/02/2001WO2001055104A1 Process for preparation of optically active n-substituted azetidine-2-carboxylic acids